Status:
RECRUITING
Clinicopathological Features and Molecular Typing of Invasive Fibroma of Abdominal Wall
Lead Sponsor:
Shandong Provincial Hospital
Conditions:
Aggressive Fibromatosis of Abdominal Wall (Disorder)
Eligibility:
All Genders
18+ years
Brief Summary
Aggressive fibromatosis, also known as desmoid fibromatosis or desmoid tumor, is a fibrous tumor that occurs in the fascia, aponeurosis, or deep soft tissue and is formed by excessive proliferation of...
Detailed Description
The data of all patients with abdominal wall aggressive fibroma were collected through the medical record system of the hospital, and the molecular characteristics of the disease were analyzed by sequ...
Eligibility Criteria
Inclusion
- ① Surgical treatment for "invasive fibroma of abdominal wall"; ② Complete clinical data; ③ Agree to participate in the project.
Exclusion
- ① can not cooperate with the project implementation; ② There is cognitive dysfunction; Refuse to participate in research projects.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06204198
Start Date
September 1 2023
End Date
September 1 2024
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shandong Provincial Hospital
Jinan, Shandong, China, 250000